Previous Close | 100.54 |
Open | 101.44 |
Bid | 83.00 x 1000 |
Ask | 103.49 x 900 |
Day's Range | 100.40 - 103.16 |
52 Week Range | 87.24 - 159.11 |
Volume | |
Avg. Volume | 498,358 |
Market Cap | 3.017B |
Beta (5Y Monthly) | 1.56 |
PE Ratio (TTM) | 53.31 |
EPS (TTM) | 1.93 |
Earnings Date | Apr 26, 2022 - May 02, 2022 |
Forward Dividend & Yield | 0.80 (0.82%) |
Ex-Dividend Date | Jun 14, 2022 |
1y Target Est | 122.50 |
LARGO, Fla., August 11, 2022--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2022 to all shareholders of record as of September 15, 2022.
CONMED (CNMD) acquires privately-held Biorez, Inc. for $85 million. The deal is set to boost CONMED's sports medicine portfolio with the addition of Biorez's proprietary BioBrace Implant technology.
LARGO, Fla., August 09, 2022--CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held Biorez, Inc.